BioLife Sciences Inc.
BioLife Sciences Inc. (BLFE) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
blfe · pe ratio · data through Nov 30, 2020
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for BioLife Sciences Inc. (BLFE) measures how much investors pay for each dollar of the company's trailing earnings. BLFE's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.02.
Source: FMP · /ratios-ttm · /analyst-estimates · 2020-11-30
PE Ratio History
2002 – 2020 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
BioLife Sciences Inc.You BLFE | $0M | N/A | — | -$0.02 |
 Bioasis Technologies Inc. BIOAF | $0M | N/A | — | -$0.04 |
 Banyan Corp. BNYN | $0M | N/A | — | -$17.79 |
 Easy Technologies Inc. EMYSF | $0M | N/A | — | -$0.07 |
 enVVeno Medical Corporation NVNO | $0M | N/A | — | -$33.06 |
 Pharmagen, Inc. PHRX | $0M | N/A | — | -$0.02 |
 Rimrock Gold Corp. RMRK | $0M | 6.78x | — | $0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2020-11-30Latest FY2020 | — | $-0.02 | — | |
2019-11-30 FY2019 | — | $-0.00 | — | |
2018-11-30 FY2018 | — | $-0.00 | — | |
2017-11-30 FY2017 | — | $-0.08 | — | |
2016-11-30 FY2016 | — | $-0.05 | — | |
2015-11-30 FY2015 | — | $-0.07 | — | |
2014-11-30 FY2014 | — | $-0.03 | — | |
2013-11-30 FY2013 | — | $-0.08 | — | |
2012-11-30 FY2012 | — | $-0.93 | — | |
2011-11-30 FY2011 | — | $-2.57 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for BioLife Sciences Inc. (BLFE) measures how much investors pay for each dollar of the company's trailing earnings. BLFE's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.02.
Frequently asked questions
BLFE pe ratio · 6 questionsBLFE's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.02. Data sourced from Financial Modeling Prep via BLFE's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BioLife Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09